| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 06/16/2005 | WO2005040386A3 A vector modification for versatile use of expressed products |
| 06/16/2005 | WO2004113539A3 Method for producing a recombinant protein of interest and protein thus produced |
| 06/16/2005 | WO2004094476A3 Compositions and methods relating to stop-1 |
| 06/16/2005 | US20050130269 Membrane protein fusion for use as diagnostic tool in genetic engineering; reporter gene expression |
| 06/16/2005 | US20050130259 Expression vector comprising nucleotide sequences coding peptidylprolyl isomerase for use as tool to improve heterologous gene expression |
| 06/16/2005 | DE10350131A1 New fusion protein, useful for treating leukemia and solid tumors, comprises specific antigen-binding, microtubulin-binding and immune response-inducing regions, also related nucleic acid |
| 06/16/2005 | DE10350122A1 New fusion protein, useful for treating leukemia and solid tumors, comprises specific antigen-binding, microtubulin-binding and immune response-inducing regions, also related nucleic acid |
| 06/16/2005 | CA2765442A1 Novel centromeric protein shugoshin |
| 06/16/2005 | CA2764400A1 Novel centromeric protein shugoshin |
| 06/16/2005 | CA2764298A1 Novel centromeric protein shugoshin |
| 06/16/2005 | CA2547655A1 Novel centromeric protein shugoshin |
| 06/15/2005 | EP1541682A2 Generation and selection of recombinant varied binding proteins |
| 06/15/2005 | EP1541679A1 Method of analyzing organelle-localized protein and materials for analysis |
| 06/15/2005 | EP1541589A1 Fused protein with the function of both hemolysis and anticoagulation and the use of it |
| 06/15/2005 | EP1539964A2 Collectin-complement activating protein chimeras |
| 06/15/2005 | EP1539957A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 06/15/2005 | EP1539813A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 06/15/2005 | EP1539809A2 Hcv fusion proteins with modified ns3 domains |
| 06/15/2005 | EP1539802A2 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 06/15/2005 | EP1539793A2 Humanized anti-lymphotoyin beta receptor antibodies |
| 06/15/2005 | EP1539786A2 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 06/15/2005 | EP1485129A4 Nanostructures containing pilin protein |
| 06/15/2005 | EP1062348B1 Recombinant onconase and fusion proteins of recombinant onconase |
| 06/15/2005 | CN1628126A Modified transferrin fusion proteins |
| 06/15/2005 | CN1626554A Interfusion protein between human serum albumin and interleukin, and encoding genes |
| 06/15/2005 | CN1205995C Hybrid polypeptides with enhanced pharmacokinetic properties |
| 06/14/2005 | US6906176 Polypeptide or use in the fibrinolysis, digestion and coagulation |
| 06/14/2005 | US6906175 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. |
| 06/14/2005 | US6906174 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 06/14/2005 | US6905832 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (APP) |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905685 Antiproliferative agents; monoclonal antibodies; blocking immunology response; autoimmune disease, antidiabetic agents, antiarthritic agents, antitumor, anticancer agents |
| 06/14/2005 | CA2100423C Parathyroid hormone analogs having parathyroid hormone-like activity |
| 06/09/2005 | WO2005051997A2 Fusion proteins and detergent compositions comprising them |
| 06/09/2005 | WO2004025264A3 Rapidly degraded reporter fusion proteins |
| 06/09/2005 | US20050124796 Mouse cytokine receptor |
| 06/09/2005 | US20050124792 Expression vector comprising nucleotide sequences coding G-protein coupled photoreceptor proteins for use in tools in pharmaceutical design; bioreactors and heterologous protein expression |
| 06/09/2005 | US20050124790 Protein fusion comprising sequences capable of being cleaved by ubiquitin cleavage enzyme; isolating heterologous expressed, recombinant polypeptide from mixture |
| 06/09/2005 | US20050124543 Heterologous polypeptide of the TNF family |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124042 Method for expression of heterologous proteins in yeast |
| 06/09/2005 | US20050124025 Chimeric protein and its use in electron transfer methods |
| 06/09/2005 | US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases |
| 06/09/2005 | US20050123558 Modifeid polypeptide |
| 06/09/2005 | US20050123534 Humanised antibodies |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | CA2547165A1 Mutated anti-cd22 antibodies and immunoconjugates |
| 06/09/2005 | CA2544448A1 Fusion proteins and detergent compositions comprising them |
| 06/08/2005 | EP1538202A2 Production of human alpha-galactosidase A |
| 06/08/2005 | EP1537237A2 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 06/08/2005 | EP1537207A2 Recombinant colstridium neurotoxin fragments |
| 06/08/2005 | EP1537145A1 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 06/08/2005 | EP0793504B1 Chimeric cytokines and uses thereof |
| 06/08/2005 | CN1625562A Chimeric delta-endotoxin protein of CRY1EA and CRY1CA |
| 06/08/2005 | CN1624126A Ret ligand (retl) for stimulating neural and renal growth |
| 06/08/2005 | CN1624115A Cell surface molecule mediating cell adhesion and signal transmission |
| 06/07/2005 | US6903203 Immunoglobulin for use in the diagnosis and therapy of cancer |
| 06/07/2005 | US6903188 Isolated functional derivative of an Mts protein that is preferably a multimeric protein complex. |
| 06/07/2005 | US6903185 Generating chimeric zinc finger protein; obtain nucleotide sequences coding chimeric protein, transform cells, express nucleotide sequences, recover protein |
| 06/07/2005 | US6902921 Genetically engineered adenosine triphosphate generating polypeptide; sequences determination; reporter molecules |
| 06/07/2005 | US6902908 Polypeptides, fusion proteins; includes production and use recombinant expression constructs having regulated promoter; mitochondria |
| 06/07/2005 | US6902731 Transcription factors; for arterial administration via stent |
| 06/07/2005 | CA2153135C Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them |
| 06/02/2005 | WO2003090514A3 Adipocyte complement related protein zacrp14 |
| 06/02/2005 | WO2003068932A8 Method for crystallizing human gsk3 and novel crystal structure thereof |
| 06/02/2005 | US20050119455 Polypeptide fusion comprising complementary determining regions for use as tool in immunotherapeutic and/or diagnostics; bioassay |
| 06/02/2005 | US20050119209 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/02/2005 | US20050118649 Monitoring protein translocation into preferential cellular compartment via reporter expression of fluorescent protein fusion |
| 06/02/2005 | US20050118575 Immune cell polypeptide for use in diagnosis and treatment of cell proliferative disorders |
| 06/02/2005 | US20050118569 Genetic engineering of streptavidin-binding peptide tagged single-chain variable fragment antibody to venezuelan equine encephalitis virus |
| 06/02/2005 | US20050118184 Compositions and methods for enhancing the immunogenicity of antigens |
| 06/02/2005 | US20050118160 Inhibits delayed vascular rejection; makes organs less vulnerable to rejection after transplantation |
| 06/02/2005 | US20050118101 Delivery across skin or blood brain barrier; such as N-(fluorescein-5-yl)-thioureido-N'-Adoa-(polylysine)7-NH2 TFA salt |
| 06/01/2005 | EP1536234A2 Soluble CTLA4 mutant molecules and uses thereof |
| 06/01/2005 | EP1535628A2 HBV/HCV virus-like particle |
| 06/01/2005 | EP1534834A2 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 06/01/2005 | EP1534756A1 Expression of hydrophobic proteins |
| 06/01/2005 | EP1534748A2 Fusion proteins and methods of producing same |
| 06/01/2005 | EP1534746A2 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 06/01/2005 | EP1534738A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 06/01/2005 | EP1534736A2 Nogo receptor antagonists |
| 06/01/2005 | EP1534730A2 Modified transferin-antibody fusion proteins |
| 06/01/2005 | EP1534315A2 Increasing of the resorption of substances via skin and mucous membranes |
| 06/01/2005 | EP1534306A2 Defensins: use as antiviral agents |
| 06/01/2005 | EP1483397A4 Oligomeric molecules and uses thereof |
| 06/01/2005 | EP1423002A4 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent |
| 06/01/2005 | EP1404362A4 Signal-1/signal-2 bifunctional peptide inhibitors |
| 06/01/2005 | EP1311162B1 Bacillus thurigiensis crystal protein hybrids |
| 06/01/2005 | EP1254179A4 An in vivo screen using chemical inducers of dimerization |
| 06/01/2005 | EP0656941B1 Methods for producing members of specific binding pairs |
| 06/01/2005 | CN1622995A Receptor nucleic acids and polypeptides |
| 06/01/2005 | CN1622957A IFNAR2 mutants, their production and use |
| 06/01/2005 | CN1621526A Recombinant adeno-associated virus for prevention and cure of I-type diabetes and use thereof |
| 06/01/2005 | CN1621418A Recombinant targeted toxin against HIV-1 |
| 06/01/2005 | CN1621411A Recombinant targeted fusion protein for treating acquired immunodeficiency syndrome |
| 06/01/2005 | CN1204257C New peptide fragments for protein purification |
| 06/01/2005 | CN1204147C Method for enhancing circulating half-life of antibody-based fusion proteins |
| 05/31/2005 | US6900304 Emission ratiometric indicators of phosphorylation |
| 05/31/2005 | US6900302 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 05/31/2005 | US6900056 Chemically defined medium for cultured mammalian cells |